je.st
news
Tag: biotech
Christian Tharp Talks The Biotech Industry And The IBB
2015-10-10 22:32:13| Biotech - Topix.net
Christian Tharp was recently a guest on #PreMarket Prep , a daily trading idea radio show hosted by Joel Elconin and Dennis Dick . The biotech expert and author of "Five-Star Stock Watch" delved into several issues, including his expectations for the broader market, his target for the S&P and other key indices and the biotech industry.
Tags: the
industry
christian
talks
Armed With FDA Orphan Drug Status in the U.S., PharmaCyte Biotech Now ...
2015-10-10 05:30:50| Biotech - Topix.net
In the world of biopharma, it doesn't take long for a company to copy or mimic a popular, successful drug. In fact, for some less-common diseases, the industry realizes that merely sharing the revenue generated by a small niche may not even be worth the effort, meaning those rare or difficult-to-treat diseases often go completely unaddressed.
The Daily Startup: Market Turbulence Puts Biotech IPOs in Question
2015-10-09 05:44:57| Biotech - Topix.net
A nearly three-month slide in the biotechnology market is prompting some venture capitalists to wonder if drug startups' sprint to the Nasdaq will slow to a crawl, Brian Gormley reports for Dow Jones VentureWire. Since late July, the Nasdaq Biotechnology Index has slipped nearly 23% amid a general market decline and the fallout from Turing Pharmaceuticals AG 's decision to hike the price of a rare-disease drug-a decision the company has since reversed.
Tags: question
market
daily
puts
Premarket Biotech Digest: Evoke Pharma Rallies, Avelumab Fast Tracked, Vertex's Milestone
2015-10-09 04:44:08| Biotech - Topix.net
There are mainly two types of tumor antigens, specific antigens and unique antigens. Shared antigens may be common to multiple cancer cells, while unique ones are expressed in specific and individual tumors only.
Tags: fast
digest
biotech
tracked
Biotech IPOs Slow to Trickle as Stock Rout Rattles Investors
2015-10-08 20:25:02| Biotech - Topix.net
The biotechnology sector's two-and-a-half-year deluge of public market debuts, with dozens of companies raising billions of dollars in funding, is now down to a trickle. After CytomX Therapeutics Inc. priced its initial public offering late Wednesday, not a single biomedical, drug or therapeutics company is expected to follow suit in the next 30 days.
Tags: stock
slow
investors
ipos
Sites : [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] next »